News & Updates

Sansanima closes seed investment round

Sansanima closed a seed round backed by Sheffield Angels, o2h Ventures, and Cambridge Angels. Funding will advance validation, pilots, adoption.

Sansanima named a Northern Gamechanger by Elevate

Elevate named Sansanima a Northern Gamechanger 2025. This recognises our work to replace animal testing in the manufacture of critical medicines.

NC3Rs case study highlights Sansanima’s animal free testing

Understanding Animal Research featured an NC3Rs case study on Sansanima’s work. It highlights human relevant assays to replace animal tests today.